Skip to main content
. 2023 Sep 19;13:15461. doi: 10.1038/s41598-023-42788-6

Figure 1.

Figure 1

The prevalence of non-alcoholic fatty liver disease (NAFLD) before and after menopausal hormone therapy (MHT) based on the route of estrogen administration. P value based on chi-square test. NS, non-significant.